share_log

HC Wainwright & Co. Maintains Buy on Context Therapeutics, Lowers Price Target to $4

HC Wainwright & Co. Maintains Buy on Context Therapeutics, Lowers Price Target to $4

HC Wainwright & Co.維持對Context Therapeutics的買入,將目標股價下調至4美元
Moomoo 24/7 ·  03/21 12:21

HC Wainwright & Co. analyst Emily Bodnar maintains Context Therapeutics (NASDAQ:CNTX) with a Buy and lowers the price target from $5 to $4.

HC Wainwright & Co. 分析師艾米麗·博德納爾維持Context Therapeutics(納斯達克股票代碼:CNTX)的買入並將目標股價從5美元下調至4美元。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論